Adverse Drug Events and Readmissions: The Global Picture

Size: px
Start display at page:

Download "Adverse Drug Events and Readmissions: The Global Picture"

Transcription

1 Adverse Drug Events and Readmissions: The Global Picture Kyle E. Hultgren, PharmD Managing Director Center for Medication Safety Advancement Purdue University College of Pharmacy Indianapolis, IN

2

3

4 4 Learning Objectives Discuss why readmissions associated with adverse drug events are a current national focus Identify the high-risk medication classes that cause ADEs Connect ADEs directly to readmissions as a frequent root cause

5 Welcome and Overview Welcome! Define terms: readmissions and ADEs Identify highrisk medications Where meds and readmissions meet Self-assessment tool

6 Center for Medication Safety Advancement Discovery of safe medication use practices Delivering knowledge to all who may benefit Innovation and collaboration between health care practitioners, faculty, staff and students Provide education, research and outreach GOAL: reduce medication errors

7 Deliverables and Expectations Highlight top 6 high-risk medication classes Think about what medications cause the most harm at your institution Self-assessment completion is encouraged

8 Step 1: Define the Terms Define terms: readmissions and ADEs Identify highrisk medications Where meds and readmissions meet

9 Readmissions One in five Medicare patients readmitted within 30 days 35% within 90 days 17 billion dollars annually ADEs implicated in ~7000 deaths Compared to inpatients, little data is available on ADEs for patients post discharge relating to medications. Jencks et al. Rehospitalizations among Patients in the Medicare Fee-for- Service Program. N Engl J Med 2009;360: Beckett RD, Sheehan AH, Redden JG. Factors Associated with Resported Preventable Adverse Drug Events: A Restrospective, Case-Control Study. Ann Pharmacotherapy. 2012;46(5):

10 Readmissions Why focus on readmissions? Measureable Good marker of care across continuum (from hospital to long term care to home etc.) Improvement in this area targets: Patient self-care and in-home care Communication between patients and providers Jencks et al. Rehospitalizations among Patients in the Medicare Fee-for- Service Program. N Engl J Med 2009;360:

11 Readmissions Penalties for readmissions Section 3025 of Affordable Care Act Hospitals with higher than expected readmission rates for HF, AMI, and Pneumonia targeted In FY13, penalized up to 1% of total Medicare revenues Up to 2% and 3% in FY14 and FY15 Conditions will be added not done here

12 Readmissions Family caregivers at home performing nursing functions 42 million family caregivers Nearly half perform nursing functions 75% perform medication managment Available from:

13 Readmissions Partnership for Patients (PfP) Reduce preventable hospital-acquired conditions by 40% by December 31, 2013 Reduce all hospital readmissions by 20% by December 31, 2013 PfP focus is on anticoagulants, narcotics, sedatives, and insulin U.S. Department of Health & Human Services Partnership for Patients. Health Research & Educational Trust. Implementation Guide to Reducing Harm from High-Alert Medications. Accessed at August 4, 2012.

14 Medication Errors 1999 Institute of Medicine (IOM) report 44,000 98,000 people per year die as a direct result of medical errors

15 Medication Errors 2006 IOM report 1.5 million preventable adverse drug events (ADE) annually in the United States Each costs ~$8,750

16 But that was 12 years ago 2010 Landrigan et al study in NEJM Randomized sample of 10 NC hospitals 100 admissions per quarter reviewed for medical errors from Jan 2002 through Dec 2007 Results 25.1 harms per 100 admissions No statistical significant drop in rate of harms over 6 years Landrigan, C et al. Temporal Trends in Rates of Patient Harm Resulting from Medical Care. New England Journal of Medicine. Nov. 25, 2010; vol 363: pp

17 Medication Errors "A medication error is any preventable event that may cause or lead to inappropriate medication use or patient harm while the medication is in the control of the health care professional, patient, or consumer. Such events may be related to professional practice, health care products, procedures, and systems, including prescribing; order communication; product labeling, packaging, and nomenclature; compounding; dispensing; distribution; administration; education; monitoring; and use. - National Coordinating Council on Medication Error Reporting and Prevention (NCC MERP)

18 Adverse Drug Events Injury resulting from medical intervention related to a drug. - Bates DM et al, JAMA 1995.

19 Adverse Drug Reactions An effect that is noxious and unintended, and which occurs at does used in man for prophylaxis, diagnosis, or therapy. - World Health Organization IMPORTANT: Includes only appropriate use of drugs.

20 Medication Errors Preventable Adverse Drug Events Adverse Drug Events ADR

21 Bad practitioner or bad system?

22 Step 2: Identify the Meds Define terms: readmissions and ADEs Identify highrisk medications Where meds and readmissions meet

23 High Risk Medications

24 Data Collection Formulate research question: Readmissions ADEs High-risk Medications Search strategy: PubMed & MEDLINE MeSH terms readmissions rehospitalizations ADEs high-risk meds high-alert meds transitions post-discharge Cross-reference

25 Data Abstraction 300+ abstracts Inclusion criteria Readmitted ADE High-risk meds Exclusion criteria Drug/alcohol abuse Article selection Limited results Analyzed occurrence of most common offending classes

26 Data Discovery and Delivery Medications Studies Why implicated Hematologic Forster, Budnitz, McDonnel, Beckett, Complexity of dosing and Classen, Ruiz, Roughead, Evans monitoring Patient adherence Drug interactions Dietary interactions Anti-diabetic Budnitz, McDonnel, Beckett, Classen Pharmacology of drugs Complexity of dosing Medication adjustments Narrow therapeutic range Anti-neoplastic Budnitz, McDonnel, Ruiz, Roughead, Pharmacology of drugs Adverse effects Dose scheduling Drug interactions Depressed immune system Analgesics (including narcotics) Cardiovascular Forster, Boockvar, Budnitz, Beckett, Evans Forster, Boockvar, Budnitz, McDonnel, Beckett, Classen, Roughead, Evans Dose mix ups Allergic reactions Enhanced CNS effects Ambiguous directions Patient adherence Polypharmacy Adverse effects Anti-infectives Forster, Budnitz, Beckett, Classen, Evans Patient adherence Overuse/misuse Kill normal flora Adverse effects/allergies Drug interactions

27 High-Risk Medications Hematologic Complexity of dosing and monitoring Patient adherence Drug interactions Dietary interactions

28 High-risk Medications Anti-diabetic Pharmacology of drugs Complexity of dosing Medication adjustments Narrow therapeutic range

29 High-Risk Medications Antineoplastics Pharmacology of drugs Adverse effects Dose scheduling Drug interactions Depressed immune system

30 High-risk Medications Analgesics (narcotics too) Dose mix ups Allergic reactions Enhanced CNS effects Ambiguous directions

31 High-risk Medications Cardiovascular Patient adherence Polypharmacy Adverse effects

32 High-Risk Medications Anti-infectives Patient adherence Overuse Misuse Kill normal flora Adverse effects Allergies Drug interactions

33 Step 3: Putting it Together Define terms: readmissions and ADEs Identify highrisk medications Where meds and readmissions meet

34 Errors in Transition Greater than 50% of medication histories taken upon admission have some form of discrepancy requiring resolution Greater than 50% of documented medication errors occur at three times: Admission Transfer Discharge Gleason, et al. Amer J Health Syst Pharm. 2004; 61: ;

35 Errors in Transition High risk meds leading to harm Narrow therapeutic window agents Family caregiving Medication histories Information systems Poor communication

36 UCSF Medical Center, CA 30-day readmissions 22% to 16% Virtual team through communication Bedside counseling totaling 90 minutes from admission to discharge Binder for heart failure and how to manage Teach-back method* Follow-up phone calls* O Reilly, KB. Reducing readmissions: How 3 hospitals found success. American Medical Association. Accessed at August 28, 2012.

37 Piedmont Hospital, GA <70yo 13.05% to 3.97% >70yo 15.9% to 11.2% Medication reconciliation done by pharmacists Identify patients at high risk Schedule follow-up care Follow-up phone call within 72 hours Discharge document (BOOST) O Reilly, KB. Reducing readmissions: How 3 hospitals found success. American Medical Association. Accessed at August 28, 2012.

38 Evergreen Hospital Medical Center, WA National heart failure rate: 24.7% 30-day hospital readmission rate: 14% and 6% for patients referred Identify high-risk patients Refer to Evergreen Cardiac Enhancement Center within 3 days 90 minute long initial session Follow-up visits Q2weeks until stable O Reilly, KB. Reducing readmissions: How 3 hospitals found success. American Medical Association. Accessed at August 28, 2012.

39 Conclusion ADEs and high-risk meds directly linked to readmissions Identify ADE associated readmissions Understand the relationship Communicate clearly

40 Next Steps Mitigation strategies Measurement methods and techniques Sharing your stories!

41 Resources Hospital Engagement Network (PfP) IHI STAAR Initiative ages/default.aspx Project RED BOOST tion=home&template=/cm/htmldisplay.cfm&conten TID=27659

42 Studies Budnitz DS, Lovegrove MC, Shehab N, et al. Emergency Hospitalizations for Adverse Drug Events in Older Americans. N Engl J Med. 2011;365: Forster AJ, Murfff HJ, Peterson JF, et al. Adverse Drug Events Occuring Following Hospital Discharge. J Gen Intern Med. 2005;20: Boockvar KS, Liu S, Goldstein N, et al. Prescribing Discrepancies Likely to Cause Adverse Drug Events after Patient Transfer. Qual Saf Health Care. 2009;18(1): McDonnell PJ, Jacobs MR. Hospital Admissions Resulting from Preventable Adverse Drug Reactions. Ann Pharmacotherapy. 2002;36: Beckett RD, Sheehan AH, Redden JG. Factors Associated with Reported Preventable Adverse Drug Events: A Restrospective, Case-Control Study. Ann Pharmacotherapy. 2012;46(5): Classen DC, Jaser L, Budnitz DS. Adverse drug events among hospitalized Medicare patients: epidemiology and national estimates from a new approach to surveillance. Jt Comm J Qual Patient Saf. 2010;36(1): Ruiz B, Garcia M, Aquirre U, et al. Factors predicting hospital readmissions related to adverse drug reactions. Eur J Clin Pharmacol. 2008; 64(7): Roughead EE, Gilbert AL, Primrose JG, et al. Drug-related hospital admissions: a review of Australian studies published Med J Aust. 1998; 168(9): Evans RS, Lloyd JF, Stoddard GJ, et al. Risk Factors for Adverse Drug Events: A 10-Year Analysis. Ann pharmacother. 2005; 39:

43 Questions?

11/15/2012. Objectives

11/15/2012. Objectives ASHP Live Webinar: Building a Medication Safety Community - Leveraging the Partnership for Patients Initiative John B. Hertig, PharmD, MS Jaclyn Jeffries, PharmD Medication Safety Project Manager Medication

More information

Objectives. Prevalence of Non-Adherence. Medications and Care Transitions. The Cost of Readmissions. The Pharmacist s Role in Improving Care 4/22/2015

Objectives. Prevalence of Non-Adherence. Medications and Care Transitions. The Cost of Readmissions. The Pharmacist s Role in Improving Care 4/22/2015 MEDS TO BEDS: DELIVERING REDUCED READMISSIONS, LOWER COSTS, AND IMPROVED QUALITY Laura S. Carr PharmD, Senior Attending Pharmacist, Transitional Care Massachusetts General Hospital Ed Cohen, PharmD, FAPhA

More information

Maryland Patient Safety Center s Annual MEDSAFE Conference: Taking Charge of Your Medication Safety Challenges November 3, 2011 The Conference Center

Maryland Patient Safety Center s Annual MEDSAFE Conference: Taking Charge of Your Medication Safety Challenges November 3, 2011 The Conference Center Maryland Patient Safety Center s Annual MEDSAFE Conference: Taking Charge of Your Medication Safety Challenges November 3, 2011 The Conference Center at the Maritime Institute Reducing Hospital Readmissions

More information

Patient Safety Opportunity (CEI)

Patient Safety Opportunity (CEI) Patient Safety Opportunity (CEI) Adverse Drug Event Surveillance Rachel Digmann, Pharm.D, BCPS Medication Safety & Program Lead Quality Innovation Network-National Coordinating Center Telligen Disclosures

More information

SO YOU WANT TO IMPROVE THE DISCHARGE PROCESS?

SO YOU WANT TO IMPROVE THE DISCHARGE PROCESS? Who are we? Why are we here? SO YOU WANT TO IMPROVE THE DISCHARGE PROCESS? Michelle Mourad MD Arpana Vidyarthi Ellen Kynoch Oh Betty Why Betty? pulmonary edema sodium intake & daily weights What makes

More information

Medication Challenges in Care Transitions: Issues Faced by Patients, Providers & Community Professionals

Medication Challenges in Care Transitions: Issues Faced by Patients, Providers & Community Professionals Medication Challenges in Care Transitions: Issues Faced by Patients, Providers & Community Professionals Joshua Akers, PharmD Geoffrey Meer, PharmD Shanna O Connor, PharmD, BCPS Introductions GROUP WORK

More information

10/27/10. Michelle Mourad MD Arpana Vidyarthi Ellen Kynoch. pulmonary edema. sodium intake & daily weights

10/27/10. Michelle Mourad MD Arpana Vidyarthi Ellen Kynoch. pulmonary edema. sodium intake & daily weights Michelle Mourad MD Arpana Vidyarthi Ellen Kynoch pulmonary edema sodium intake & daily weights 1 What makes her at risk for readmission? Why didn t she listen to her doctors about her salt intake? Did

More information

Best Practices for Safety & Care Coordination

Best Practices for Safety & Care Coordination Best Practices for Safety & Care Coordination Thursday, February 23, 2016 Nicole Skyer-Brandwene MS, RPh, BCPS, CCP Adverse Drug Events Network Task Lead Andrew Miller, MD, MPH Care Coordination Network

More information

Who Cares About Medication Reconciliation? American Pharmacists Association American Society of Health-system Pharmacists The Joint Commission Agency

Who Cares About Medication Reconciliation? American Pharmacists Association American Society of Health-system Pharmacists The Joint Commission Agency The Impact of Medication Reconciliation Jeffrey W. Gower Pharmacy Resident Saint Alphonsus Regional Medical Center Objectives Understand the definition and components of effective medication reconciliation

More information

Optimizing pharmaceutical care via Health Information Technology:

Optimizing pharmaceutical care via Health Information Technology: Optimizing pharmaceutical care via Health Information Technology: The Epic Challenge Rilwan Badamas, PharmD, CAHIMS Pharmacy Grand Rounds 01/03/2017 2011 MFMER slide-1 The medication management team requests

More information

Adverse Events in Hospitals: How Many and Why Not Reported. Fran Griffin Senior Manager Clinical Programs, BD

Adverse Events in Hospitals: How Many and Why Not Reported. Fran Griffin Senior Manager Clinical Programs, BD Adverse Events in Hospitals: How Many and Why Not Reported Fran Griffin Senior Manager Clinical Programs, BD Disclosure Currently full time employed at BD and faculty at The Institute for Healthcare Improvement

More information

Learning Objectives. Putting Patient Safety First: Trends in Adverse Drug Event

Learning Objectives. Putting Patient Safety First: Trends in Adverse Drug Event Learning Objectives Putting Patient Safety First: Trends in Adverse Drug Event Screening and Reporting Charlene A. Hope, PharmD, BCPS Izabella Wentz, PharmD, FASCP Moderator PHARMACISTS 1. Differentiate

More information

Key Words: Transitions of care, care coordination, medication management, drug therapy problem

Key Words: Transitions of care, care coordination, medication management, drug therapy problem Implementing a Pharmacist-Led Medication Management Pilot to Improve Care Transitions Rachel Root, PharmD, MS* 1, Pamela Phelps, PharmD, FASHP 2, Amanda Brummel, PharmD 2, and Craig Else, PharmD, MBA 3

More information

Avoiding Errors During Transitions of Care: Medication Reconciliation

Avoiding Errors During Transitions of Care: Medication Reconciliation in in Practice Avoiding Errors During Transitions of Care: Medication Reconciliation When medication errors occur, they often are the result of discrepancies in medication information during transitions

More information

Reducing Readmission Rates in Heart Failure and Acute Myocardial Infarction by Pharmacy Intervention

Reducing Readmission Rates in Heart Failure and Acute Myocardial Infarction by Pharmacy Intervention Journal of Pharmacy and Pharmacology 2 (2014) 731-738 doi: 10.17265/2328-2150/2014.12.006 D DAVID PUBLISHING Reducing Readmission Rates in Heart Failure and Acute Myocardial Infarction by Pharmacy Intervention

More information

Medication Safety Action Bundle Adverse Drug Events (ADE) All High-Risk Medication Safety

Medication Safety Action Bundle Adverse Drug Events (ADE) All High-Risk Medication Safety Medication Safety Action Bundle Adverse Drug Events (ADE) All High-Risk Medication Safety Background The Institute of medicine (IOM) estimates that 1.5 million preventable Adverse Drug Events (ADE) occur

More information

Background and Methodology

Background and Methodology Study Sites and Investigators Emergency Department Pharmacists Improve Patient Safety: Results of a Multicenter Study Supported by the ASHP Foundation Jeffrey Rothschild, MD, MPH-Principal Investigator

More information

Medication Reconciliation Project Edmonton Zone Steps To MedRec Success Across Multiple Programs and Sites in a Large Urban Setting

Medication Reconciliation Project Edmonton Zone Steps To MedRec Success Across Multiple Programs and Sites in a Large Urban Setting Medication Reconciliation Project Edmonton Zone Steps To MedRec Success Across Multiple Programs and Sites in a Large Urban Setting Natalie McMurtry, BSc Pharm, Sr. Medication Consultant; Vanessa Moorgen,

More information

Transitions of Care. ACOI Clinical Challenges in Inpatient Care. March 31, 2016 John B. Bulger, DO, MBA

Transitions of Care. ACOI Clinical Challenges in Inpatient Care. March 31, 2016 John B. Bulger, DO, MBA Transitions of Care ACOI Clinical Challenges in Inpatient Care March 31, 2016 John B. Bulger, DO, MBA Disclosure I have not accepted any honoraria, additional payments of reimbursements related to the

More information

POLICY BRIEF. Identifying Adverse Drug Events in Rural Hospitals: An Eight-State Study. May rhrc.umn.edu. Background.

POLICY BRIEF. Identifying Adverse Drug Events in Rural Hospitals: An Eight-State Study. May rhrc.umn.edu. Background. POLICY BRIEF Identifying Adverse Drug Events in Rural Hospitals: An Eight-State Study Michelle Casey, MS Peiyin Hung, MSPH Emma Distel, MPH Shailendra Prasad, MBBS, MPH Key Findings In 2013, Critical Access

More information

PHARMACY SERVICES/MEDICATION USE

PHARMACY SERVICES/MEDICATION USE 25.01. 10 Drug Reactions & Administration Errors & Incompatibilities. Drug administration errors, adverse drug reactions and incompatibilities must be immediately reported to the attending physician and

More information

Pharmacy s Role in Decreasing Hospital Readmissions

Pharmacy s Role in Decreasing Hospital Readmissions Pharmacy s Role in Decreasing Hospital Readmissions ACPE UAN 107-000-11-004-L04-P & 107-000-11-004-L04-T Activity Type: Knowledge-Based 0.15 CEU/1.5 Hr Program Objectives for Pharmacists: Upon completion

More information

Adverse Drug Events in Wyoming

Adverse Drug Events in Wyoming Adverse Drug Events in Wyoming Where We Are and Where We Need to Go Stevi Sy, PharmD, RPh Adverse Drug Event Task Lead Mountain-Pacific Quality Health August 2017 Objectives Upon completion of this program

More information

Bulletin Independent prescribing information for NHS Wales

Bulletin Independent prescribing information for NHS Wales Bulletin Independent prescribing information for NHS Wales Medicines-related admissions February 2015 Although medicines play an important role in the management of chronic and acute illnesses, they can

More information

PREVENTING HOSPITAL READMISSIONS: PHARMACISTS ROLE IN TRANSITIONS OF CARE

PREVENTING HOSPITAL READMISSIONS: PHARMACISTS ROLE IN TRANSITIONS OF CARE PREVENTING HOSPITAL READMISSIONS: PHARMACISTS ROLE IN TRANSITIONS OF CARE RAJEEV KUMAR MD FACP CHIEF MEDICAL OFFICER SYMBRIA OBJECTIVES Identify elements of key literature that describes post-hospital

More information

Medication Management: Is It in Your Toolbox?

Medication Management: Is It in Your Toolbox? Medication Management: Is It in Your Toolbox? Brian K. Esterly, MBA, SVP, Corporate Development, excellerx, Inc. O: 215.282.1676, besterly@excellerx.com What has been your Medication Management experience?

More information

A23/B23: Patient Harm in US Hospitals: How Much? Objectives

A23/B23: Patient Harm in US Hospitals: How Much? Objectives A23/B23: Patient Harm in US Hospitals: How Much? 23rd Annual National Forum on Quality Improvement in Health Care December 6, 2011 Objectives Summarize the findings of three recent studies measuring adverse

More information

H2H Mind Your Meds "Challenge. Webinar #3- Lessons Learned Wednesday, April 18, :00 pm 3:00 pm ET. Welcome

H2H Mind Your Meds Challenge. Webinar #3- Lessons Learned Wednesday, April 18, :00 pm 3:00 pm ET. Welcome H2H Mind Your Meds "Challenge Webinar #3- Lessons Learned Wednesday, April 18, 2012 2:00 pm 3:00 pm ET 1 Welcome Take Home Messages Understand how to implement the Mind Your Meds strategies and tools in

More information

Deborah Perian, RN MHA CPHQ. Reduce Unplanned Hospital Admissions: Focus on Patient Safety

Deborah Perian, RN MHA CPHQ. Reduce Unplanned Hospital Admissions: Focus on Patient Safety Deborah Perian, RN MHA CPHQ Reduce Unplanned Hospital Admissions: Focus on Patient Safety Objectives At the end of this lesson, the learner will be able to: Identify key clinical and policy issues associated

More information

4/28/2017. Medication Management for Improved Compliance & Home Care Satisfaction PREPARED FOR NEHCC Presenter. Overview

4/28/2017. Medication Management for Improved Compliance & Home Care Satisfaction PREPARED FOR NEHCC Presenter. Overview Medication Management for Improved Compliance & Home Care Satisfaction PREPARED FOR NEHCC 2017 Presenter Debra Demar, MS is the Community Liaison for White Cross Pharmacy, serving RI, MA and CT. She has

More information

IMPROVING CARE TRANSITIONS: Optimizing Medication Reconciliation

IMPROVING CARE TRANSITIONS: Optimizing Medication Reconciliation IMPROVING CARE TRANSITIONS: Optimizing Medication Reconciliation MARCH 2012 Improving Care Transitions: Optimizing Medication Reconciliation Developed by: American Pharmacists Association American Society

More information

One or More Errors in 67% of the IV Infusions: Insights from a Study of IV Medication Administration

One or More Errors in 67% of the IV Infusions: Insights from a Study of IV Medication Administration One or More Errors in 67% of the IV Infusions: Insights from a Study of IV Medication Administration Presented by: Marla Husch Northwestern Memorial Hospital Northwestern Memorial Hospital Chicago, Illinois

More information

Marshall Digital Scholar. Marshall University. Brittany Snodgrass. Charles K. Babcock Marshall University,

Marshall Digital Scholar. Marshall University. Brittany Snodgrass. Charles K. Babcock Marshall University, Marshall University Marshall Digital Scholar Pharmacy Practice & Administration Faculty Research 2013 The impact of a community pharmacist conducted comprehensive medication review (CMR) on 30-day re-admission

More information

Medication Reconciliation Bundle of Care. Margaret Duguid, Pharmaceutical Advisor Singapore, 21 August 2013

Medication Reconciliation Bundle of Care. Margaret Duguid, Pharmaceutical Advisor Singapore, 21 August 2013 Medication Reconciliation Bundle of Care Margaret Duguid, Pharmaceutical Advisor Singapore, 21 August 2013 Overview Problem of medication errors at transitions of care Who is at risk Recognition as a patient

More information

Measuring Medication Harm: Advantages of Using a Trigger Tool. Frank Federico Executive Director

Measuring Medication Harm: Advantages of Using a Trigger Tool. Frank Federico Executive Director Measuring Medication Harm: Advantages of Using a Trigger Tool Frank Federico Executive Director ffederico@ihi.org Objectives Review the use of the trigger tool Discuss how to use the trigger tool for high-alert

More information

PRISM Collaborative: Transforming the Future of Pharmacy PeRformance Improvement for Safe Medication Management

PRISM Collaborative: Transforming the Future of Pharmacy PeRformance Improvement for Safe Medication Management PRISM Collaborative: Transforming the Future of Pharmacy PeRformance Improvement for Safe Medication Management Mission: To improve the health of the people of Connecticut through safe and effective medication

More information

Using Data to Inform Quality Improvement

Using Data to Inform Quality Improvement 20 15 10 5 0 Using Data to Inform Quality Improvement Ethan Kuperman, MD FHM Aparna Kamath, MD MS Justin Glasgow, MD PhD Disclosures None of the presenters today have relevant personal or financial conflicts

More information

Pharm2Pharm Standard Operating Procedures. University of Hawai i at Hilo The Daniel K. Inouye College of Pharmacy Center for Rural Health Science

Pharm2Pharm Standard Operating Procedures. University of Hawai i at Hilo The Daniel K. Inouye College of Pharmacy Center for Rural Health Science Pharm2Pharm Standard Operating Procedures University of Hawai i at Hilo The Center for Rural Health Science INTRODUCTION PURPOSE: The purpose of the Pharm2Pharm Standard Operating Procedures (SOPs) is:

More information

Pharmacists in Transitions of Care: We Can All Make a Difference

Pharmacists in Transitions of Care: We Can All Make a Difference Pharmacists in Transitions of Care: We Can All Make a Difference Disclosure The speakers of this panel have no actual or potential conflict of interest in relation to this program to disclose. Kenda Germain,

More information

Poor admission medication reconciliation can follow

Poor admission medication reconciliation can follow Importance of Medication Reconciliation in the Continuum of Care Cynthia R. Hennen, BS, RPh; and James A. Jorgenson, RPh, MS, FASHP Specialty Healthcare Benefits Council Poor admission medication reconciliation

More information

Transition of Care Practices. Nancy MacDonald, PharmD, BCPS, FASHP Henry Ford Hospital Detroit, MI

Transition of Care Practices. Nancy MacDonald, PharmD, BCPS, FASHP Henry Ford Hospital Detroit, MI Transition of Care Practices Nancy MacDonald, PharmD, BCPS, FASHP Henry Ford Hospital Detroit, MI Objectives Pharmacist 1. Describe transition of care opportunities 2. Explain ways to use pharmacist extenders

More information

Fostering a Culture of Safety

Fostering a Culture of Safety Fostering a Culture of Safety June 11, 2017 Alabama Society of Health System Pharmacists Presenter: Trey Gwin, RPh, MBA, Medication Safety Coordinator, Infirmary Health Financial Disclosure The speaker

More information

Medication Adherence

Medication Adherence Medication Adherence Robert DiGregorio, PharmD, FNAP, BCACP Professor (Long Island University) Sr. Director, Pharmacy & Pharmacotherapy Services (TBHC) Chief, Pharmacotherapy Department of Internal Medicine

More information

Pharmacists Role in Care Transitions

Pharmacists Role in Care Transitions Pharmacists Role in Care Transitions SHE A FA NNING, PHA RMD, PGY 1 PHA RMA C Y RE SIDENT ST. PETER S HOSPITAL HE LE NA, MT Disclosures Co-investigators: Thomas Richardson, PharmD, BCPS AQ-ID; Brad Hornung,

More information

Disclosure. SwedishAmerican Hospital A Division of UW Health. Learning Objectives. Medication History. Medication History 2/2/2017

Disclosure. SwedishAmerican Hospital A Division of UW Health. Learning Objectives. Medication History. Medication History 2/2/2017 Disclosure Pharmacy Technician- Acquired Medication Histories in the ED: A Path to Higher Quality of Care David Huhtelin, PharmD Emergency Medicine Clinical Pharmacist SwedishAmerican Hospital A Division

More information

Administrative Update: How to Implement Discharge Pharmacy Services (DPS) Objectives

Administrative Update: How to Implement Discharge Pharmacy Services (DPS) Objectives Administrative Update: How to Implement Discharge Pharmacy Services (DPS) Morgan Pendleton, PharmD, BCOP Hematology/Oncology Clinical Pharmacist Wake Forest Baptist Health Objectives Evaluate the need

More information

Improving Transitions of Care

Improving Transitions of Care Improving Transitions of Care Mark V. Williams, MD, FACP, FHM Professor & Chief, Division of Hospital Medicine Northwestern University Feinberg School of Medicine Principal Investigator, Project BOOST

More information

TRANSITIONS of CARE. Francis A. Komara, D.O. Michigan State University College of Osteopathic Medicine

TRANSITIONS of CARE. Francis A. Komara, D.O. Michigan State University College of Osteopathic Medicine TRANSITIONS of CARE Francis A. Komara, D.O. Michigan State University College of Osteopathic Medicine 5-15-15 Objectives At the conclusion of the presentation, the participant will be able to: 1. Improve

More information

COLLABORATIVE PRACTICE SUCCESSES IN PRIMARY CARE

COLLABORATIVE PRACTICE SUCCESSES IN PRIMARY CARE COLLABORATIVE PRACTICE SUCCESSES IN PRIMARY CARE KPhA Annual Meeting September 7, 2014 Tiffany R. Shin, PharmD, BCACP Lyndsey N. Hogg, PharmD, BCACP Objectives Describe basic concepts of collaborative

More information

IMPACT OF TECHNOLOGY ON MEDICATION SAFETY

IMPACT OF TECHNOLOGY ON MEDICATION SAFETY Continuous Quality Improvement IMPACT OF Steven R. Abel, PharmD, FASHP TECHNOLOGY ON Nital Patel, PharmD. MBA MEDICATION SAFETY Sheri Helms, PharmD Candidate Brian Heckman, PharmD Candidate Ismaila D Badjie

More information

Rita Shane, Pharm.D., FASHP, FCSHP Chief Pharmacy Officer Cedars-Sinai Medical Center Asst. Dean, Clinical Pharmacy, UCSF School of Pharmacy

Rita Shane, Pharm.D., FASHP, FCSHP Chief Pharmacy Officer Cedars-Sinai Medical Center Asst. Dean, Clinical Pharmacy, UCSF School of Pharmacy Rita Shane, Pharm.D., FASHP, FCSHP Chief Pharmacy Officer Cedars-Sinai Medical Center Asst. Dean, Clinical Pharmacy, UCSF School of Pharmacy Describe the transformation of health-systems in response to

More information

What is Transition of Care?

What is Transition of Care? Transitions of Care and Reducing Readmissions Jackie Vance, RN, CDONA, FACDONA Director of Clinical Affairs and Industry Relations, AMDA NTOCC is chaired and coordinated by CMSA in partnership with sanofi

More information

Importance of Clinical Leadership in Pharmacy

Importance of Clinical Leadership in Pharmacy Importance of Clinical Leadership in Pharmacy Rita Shane, Pharm.D., FASHP, FCSHP Chief Pharmacy Officer Cedars-Sinai Medical Center, Los Angeles Assistant Dean, Clinical Pharmacy UCSF School of Pharmacy

More information

Preventing Adverse Drug Events and Harm

Preventing Adverse Drug Events and Harm Preventing Adverse Drug Events and Harm Frank Federico, RPh, IHI Executive Director Steve Meisel, PharmD, IHI Faculty March 27th,2012 12:00-1:00pm ET Beth O Donnell, MPH Beth O Donnell, MPH, Institute

More information

High Alert Medications: Reducing Patient Harm

High Alert Medications: Reducing Patient Harm High Alert Medications: Reducing Patient Harm Building a Bridge to Better Health Coalition Brian D. Esters, PharmD, CPPS Assistant Professor of Pharmacy Practice Tennessee Pharmacist Coalition Vision Reduce

More information

Transitions of Care. Objectives 1/6/2016. Roman Digilio, PharmD PGY1 Resident West Kendall Baptist Hospital. The author has nothing to disclose.

Transitions of Care. Objectives 1/6/2016. Roman Digilio, PharmD PGY1 Resident West Kendall Baptist Hospital. The author has nothing to disclose. Transitions of Care Roman Digilio, PharmD PGY1 Resident West Kendall Baptist Hospital 1 The author has nothing to disclose. 2 Objectives Discuss current healthcare trends and the need for pharmacists in

More information

Medication Reconciliation

Medication Reconciliation Medication Reconciliation Where are we now? Angie Powell, PharmD Director of Pharmacy Baxter Regional Medical Center Disclosures I, Angie Powell, have no relevant financial relationships to disclose. Learning

More information

Neighborhoods, resources and capacity to improve

Neighborhoods, resources and capacity to improve Neighborhoods, resources and capacity to improve Jane Brock, MD, MSPH Telligen QIN QIO National Coordinating Center This material was prepared by Telligen, the Quality Innovation Network National Coordinating

More information

Strategies for Successful Medication Reconciliation and Management. Steve Kennedy, PharmD Paula Zelle, PharmD, FASHP

Strategies for Successful Medication Reconciliation and Management. Steve Kennedy, PharmD Paula Zelle, PharmD, FASHP Strategies for Successful Medication Reconciliation and Management Steve Kennedy, PharmD Paula Zelle, PharmD, FASHP Disclosures The speakers declare no conflicts of interest or financial interest in any

More information

Implementation Guide: Critical Interventions in the First/Second Visit. VNAA Best Practice for Home Health

Implementation Guide: Critical Interventions in the First/Second Visit. VNAA Best Practice for Home Health Implementation Guide: Critical Interventions in the First/Second Visit VNAA Best Practice for Home Health Learning Objectives The participant will be able to: Identify three interventions that should take

More information

Disease State Management Clinics: A Pharmacist Perspective

Disease State Management Clinics: A Pharmacist Perspective Disease State Management Clinics: A Pharmacist Perspective Eva Berrios Colon, Pharm.D, MPH, BCPS Associate Professor, Touro College of Pharmacy Email: evb9001@nyp.org 5/12/11 The Brooklyn Hospital Center

More information

Strategies for Successful Medication Reconciliation and Management

Strategies for Successful Medication Reconciliation and Management Strategies for Successful Medication Reconciliation and Management Steve Kennedy, PharmD Paula Zelle, PharmD, FASHP Disclosures The speakers declare no conflicts of interest or financial interest in any

More information

3/9/2010. Objectives. Pharmacist Role in Medication Safety and Regulatory Compliance

3/9/2010. Objectives. Pharmacist Role in Medication Safety and Regulatory Compliance Pharmacist Role in Medication Safety and Regulatory Compliance Janet Greiwe Vice President, Systems Management Cleveland County Health System Objectives By the end of this presentation, you should be able

More information

4/2/2018. Objectives. Victoria Stanislovaitis, PharmD. Medication Reconciliation (Med Rec) Victoria M. Stanislovaitis, PharmD. RockMED LTC Pharmacy

4/2/2018. Objectives. Victoria Stanislovaitis, PharmD. Medication Reconciliation (Med Rec) Victoria M. Stanislovaitis, PharmD. RockMED LTC Pharmacy Medication Reconciliation (Med Rec) Victoria M. Stanislovaitis, PharmD RockMED LTC Pharmacy Objectives Definitions Explain the importance of medication reconciliation Learn the duties and responsibilities

More information

The Role of the Agency for Healthcare Research and Quality (AHRQ) in the US Drug Safety System

The Role of the Agency for Healthcare Research and Quality (AHRQ) in the US Drug Safety System The Role of the Agency for Healthcare Research and Quality (AHRQ) in the US Drug Safety System Scott R. Smith, MSPH, PhD Center for Outcomes & Evidence Agency for Healthcare Research & Quality July 20,

More information

Medication Safety Quality Improvement: Collaboration to Reduce Adverse Drug Events

Medication Safety Quality Improvement: Collaboration to Reduce Adverse Drug Events Medication Safety Quality Improvement: Collaboration to Reduce Adverse Drug Events Jayme Steig, PharmD, RPh Quality Improvement Specialist - Pharmacy Quality Health Associates of North Dakota Disclosure

More information

IHI Expedition. Reducing Readmissions by Improving Care Transitions Session 2. Expedition Coordinator

IHI Expedition. Reducing Readmissions by Improving Care Transitions Session 2. Expedition Coordinator Thursday, June 20, 2013 These presenters have nothing to disclose IHI Expedition Reducing Readmissions by Improving Care Transitions Session 2 Peg Bradke, RN, MA Saranya Loehrer, MD, MPH Expedition Coordinator

More information

Understanding Patient Choice Insights Patient Choice Insights Network

Understanding Patient Choice Insights Patient Choice Insights Network Quality health plans & benefits Healthier living Financial well-being Intelligent solutions Understanding Patient Choice Insights Patient Choice Insights Network SM www.aetna.com Helping consumers gain

More information

A Layered Learning Medication Reconciliation Program

A Layered Learning Medication Reconciliation Program A Layered Learning Medication Reconciliation Program Brittany Bates, PharmD, BCPS Clinical Pharmacist, Lima Memorial Health System Clinical Assistant Professor, Ohio Northern University Jana Randolph,

More information

MediServe. More than 25 Years Serving the Rehab and Respiratory Communities

MediServe. More than 25 Years Serving the Rehab and Respiratory Communities MediServe More than 25 Years Serving the Rehab and Respiratory Communities Who We Are Respiratory Rehabilitation 250+ Clients Chandler, Arizona 26+ yrs of business CORE Focus (Compliance, Outcomes, Revenue,

More information

MEDICATION USE EFFECTIVE DATE: 06/2003 REVISED: 2/2005, 04/2008, 06/2014

MEDICATION USE EFFECTIVE DATE: 06/2003 REVISED: 2/2005, 04/2008, 06/2014 TITLE / DESCRIPTION: SAFETY PROCEDURES FOR MEDICATION USE DEPARTMENT: Pharmacy PERSONNEL: All Pharmacy Personnel EFFECTIVE DATE: 06/2003 REVISED: 2/2005, 04/2008, 06/2014 Leadership and Culture A culture

More information

Medication Therapy Management

Medication Therapy Management Medication Therapy Management Presented by Sylvia Saade, PharmD Ghada Khoury, Pharm D, BCACP Objectives Describe the components of medication therapy management (MTM) programs Discuss the needs of MTM

More information

THE BEST OF TIMES: PHARMACY IN AN ERA OF

THE BEST OF TIMES: PHARMACY IN AN ERA OF OBJECTIVES THE BEST OF TIMES: PHARMACY IN AN ERA OF ACCOUNTABLE CARE Toni Fera, BS, PharmD October 17, 2014 1. Describe the role of pharmacists in accountable care organizations (ACO). 2. List four key

More information

Improving Clinical Outcomes

Improving Clinical Outcomes Improving clinical outcomes and reducing health care costs under the Affordable Care Act - are enhanced medication management strategies part of the solution? Sandra L. Baldinger, Pharm.D., M.S. Kenneth

More information

Lost in Transition. Definition. Objectives 9/22/2014

Lost in Transition. Definition. Objectives 9/22/2014 Lost in Transition Eliza Borzadek, RN, Pharm.D., BCPS Idaho State University eliza@fmed.isu.edu ISHP Annual Fall Conference: September 26-28, 2014 Objectives 1. Describe the background and history of transitions

More information

STRATEGIES AND SOLUTIONS FOR REDUCING INAPPROPRIATE READMISSIONS

STRATEGIES AND SOLUTIONS FOR REDUCING INAPPROPRIATE READMISSIONS WHITE PAPER STRATEGIES AND SOLUTIONS FOR REDUCING INAPPROPRIATE READMISSIONS This paper offers a two-pronged approach to lower readmission rates and avoid Federal penalties. Jasen W. Gundersen, M.D., M.B.A.,

More information

Medication Errors in Chemotherapy PORSCHA L. JOHNSON, PHARM.D. CLINICAL PHARMACIST II MEDSTAR WASHINGTON HOSPITAL CENTER SATURDAY, SEPTEMBER 17, 2016

Medication Errors in Chemotherapy PORSCHA L. JOHNSON, PHARM.D. CLINICAL PHARMACIST II MEDSTAR WASHINGTON HOSPITAL CENTER SATURDAY, SEPTEMBER 17, 2016 Medication Errors in Chemotherapy PORSCHA L. JOHNSON, PHARM.D. CLINICAL PHARMACIST II MEDSTAR WASHINGTON HOSPITAL CENTER SATURDAY, SEPTEMBER 17, 2016 DISCLOSURE STATEMENT I have nothing to disclose regarding

More information

Hospital Readmissions Survival Guide

Hospital Readmissions Survival Guide WHITE PAPER Hospital Readmissions Survival Guide The Long-Term Care Provider s Ultimate Survival Guide to Incorporating INTERACT into Health Information Technology (HIT) March 2017 In this survival guide,

More information

Reducing Hospital Re-Admissions with Telemedicine & Medication Reconciliation The prescription for improved patient outcomes

Reducing Hospital Re-Admissions with Telemedicine & Medication Reconciliation The prescription for improved patient outcomes Reducing Hospital Re-Admissions with Telemedicine & Medication Reconciliation The prescription for improved patient outcomes Download the presentation at RxConcile.com or asaging.org Who we are Chad Worz

More information

Managing Pharmaceuticals to Reduce Medication Errors August 26, 2003

Managing Pharmaceuticals to Reduce Medication Errors August 26, 2003 Managing Pharmaceuticals to Reduce Medication Errors August 26, 2003 Susan M. Proulx, Pharm.D. President, Med-E.R.R.S. Subsidiary of ISMP (www.med-errs.com) Mission of ISMP Translate errors into education

More information

Impact of an Innovative ADC System on Medication Administration

Impact of an Innovative ADC System on Medication Administration Impact of an Innovative ADC System on Medication Administration March 1, 2016 Nilesh Desai, BS, RPh, MBA Administrator Pharmacy and Clinical Operations Hackensack University Medical Center Conflict of

More information

W e were aware that optimising medication management

W e were aware that optimising medication management 207 QUALITY IMPROVEMENT REPORT Improving medication management for patients: the effect of a pharmacist on post-admission ward rounds M Fertleman, N Barnett, T Patel... See end of article for authors affiliations...

More information

Professional Student Outcomes (PSOs) - the academic knowledge, skills, and attitudes that a pharmacy graduate should possess.

Professional Student Outcomes (PSOs) - the academic knowledge, skills, and attitudes that a pharmacy graduate should possess. Professional Student Outcomes (PSOs) - the academic knowledge, skills, and attitudes that a pharmacy graduate should possess. Number Outcome SBA SBA-1 SBA-1.1 SBA-1.2 SBA-1.3 SBA-1.4 SBA-1.5 SBA-1.6 SBA-1.7

More information

New pharmacy practice opportunity: Enhancement of the transitions of care process

New pharmacy practice opportunity: Enhancement of the transitions of care process New pharmacy practice opportunity: Enhancement of the transitions of care process EMMA GORMAN, PHARMD CLINICAL ASSISTANT PROFESSOR DEPARTMENT OF PHARMACY PRACTICE D YOUVILLE SCHOOL OF PHARMACY BUFFALO,

More information

COMPUTERIZED PHYSICIAN ORDER ENTRY (CPOE)

COMPUTERIZED PHYSICIAN ORDER ENTRY (CPOE) COMPUTERIZED PHYSICIAN ORDER ENTRY (CPOE) Ahmed Albarrak 301 Medical Informatics albarrak@ksu.edu.sa 1 Outline Definition and context Why CPOE? Advantages of CPOE Disadvantages of CPOE Outcome measures

More information

UNDERSTANDING THE CONTENT OUTLINE/CLASSIFICATION SYSTEM

UNDERSTANDING THE CONTENT OUTLINE/CLASSIFICATION SYSTEM BOARD OF PHARMACY SPECIALTIES CRITICAL CARE PHARMACY SPECIALIST CERTIFICATION CONTENT OUTLINE/CLASSIFICATION SYSTEM FINALIZED SEPTEMBER 2017/FOR USE ON FALL 2018 EXAMINATION AND FORWARD UNDERSTANDING THE

More information

Novel combined patient instruction and discharge summary tool improves timeliness of documentation and outpatient provider satisfaction

Novel combined patient instruction and discharge summary tool improves timeliness of documentation and outpatient provider satisfaction 701053SMO0010.1177/2050312117701053SAGE Open MedicineGilliam et al. research-article2017 Original Article SAGE Open Medicine Novel combined patient instruction and discharge summary tool improves timeliness

More information

Improving patient discharge process using electronic medication input tool and on-line guide to arranging follow-ups

Improving patient discharge process using electronic medication input tool and on-line guide to arranging follow-ups BMJ Quality Improvement Reports 2013; u756.w711 doi: 10.1136/bmjquality.u756.w711 Improving patient discharge process using electronic medication input tool and on-line guide to arranging follow-ups Rory

More information

Who s s on What? Latest Experience with the Framework Challenges and Successes. November 29, Margaret Colquhoun Project Leader ISMP Canada

Who s s on What? Latest Experience with the Framework Challenges and Successes. November 29, Margaret Colquhoun Project Leader ISMP Canada Who s s on What? Latest Experience with the Framework Challenges and Successes November 29, 2005 Margaret Colquhoun Project Leader ISMP Canada 1 Outline ISMP Canada Partnership with SHN The Canadian Getting

More information

2017 LEAPFROG TOP HOSPITALS

2017 LEAPFROG TOP HOSPITALS 2017 LEAPFROG TOP HOSPITALS METHODOLOGY AND DESCRIPTION In order to compare hospitals to their peers, Leapfrog first placed each reporting hospital in one of the following categories: Children s, Rural,

More information

Presentation Outline

Presentation Outline Pharmacist Practice Expectations Weighing Value and Setting Priorities Nick Honcharik, Pharm. D. Presentation Outline Pharmacist Practice Expectations Background/rationale Development Selective examples

More information

Medication Trauma Crisis: Primary Care Innovations. Session Code: D25, E25

Medication Trauma Crisis: Primary Care Innovations. Session Code: D25, E25 Medication Trauma Crisis: Primary Care Innovations Session Code: D25, E25 Speakers and Disclosures Speaker James Slater, PharmD Executive Pharmacy Director, CareOregon Kristen Benkstein, PharmD Pharmacy

More information

Brittany Turner, 2015 PharmD Candidate 1 Justin Campbell, PharmD 2 Katie McKinney, PharmD, MS, BCPS 2

Brittany Turner, 2015 PharmD Candidate 1 Justin Campbell, PharmD 2 Katie McKinney, PharmD, MS, BCPS 2 Discharge Medication Concierge Program: A pilot project in heart failure to reduce readmission rates, improve patient satisfaction, and increase pharmacy business metrics Brittany Turner, 2015 PharmD Candidate

More information

Objectives. Medication Therapy Management: The Important Role of the Pharmacy Technician. Medication Therapy Management (MTM)

Objectives. Medication Therapy Management: The Important Role of the Pharmacy Technician. Medication Therapy Management (MTM) Medication Therapy Management: The Important Role of the Pharmacy Technician Nancy Myers, PharmD, MBA, BCPS, CDE Katrina Harper, PharmD, MBA Objectives Define Medication Therapy Management () and its Core

More information

Chapter 38. Medication Reconciliation

Chapter 38. Medication Reconciliation Chapter 38. Medication Reconciliation Jane H. Barnsteiner Background According to the Institute of Medicine s Preventing Medication Errors report, 1 the average hospitalized patient is subject to at least

More information

Medication Errors Assessment and Prevention by a Clinical Pharmacist in Pediatric Wards. Peshawar, KPK-Pakistan. Original Article.

Medication Errors Assessment and Prevention by a Clinical Pharmacist in Pediatric Wards. Peshawar, KPK-Pakistan. Original Article. Original Article Medication Errors Assessment and Prevention by a Clinical Pharmacist in Pediatric Wards of RMI Hospital Peshawar, KPK-Pakistan ABSTRACT Background: Medication errors are the most common

More information

Pharmacy Technicians and Interns: Charting New Territory

Pharmacy Technicians and Interns: Charting New Territory Pharmacy Technicians and Interns: Charting New Territory Peter Dippel Pharm.D, BCPS Clinical Pharmacist II Baptist Health Medical Center NLR Objectives Understand what Pharmacist Extenders are and why

More information

Understanding and improving the quality of medication use: Research in Clinical Pharmacy starting from Academia. Anne Spinewine

Understanding and improving the quality of medication use: Research in Clinical Pharmacy starting from Academia. Anne Spinewine Understanding and improving the quality of medication use: Research in Clinical Pharmacy starting from Academia Clinical Pharmacy Research Group (CLIP) Anne Spinewine 1 04.10.2011 WBI- UCL Research activities

More information

PACE Performance on Post-Discharge Primary Care Evaluations from Jan-Jun 2012 PACE. By: Rocio Solano Padilla PCLP-NMF/GE Scholar Jul 23, 2012

PACE Performance on Post-Discharge Primary Care Evaluations from Jan-Jun 2012 PACE. By: Rocio Solano Padilla PCLP-NMF/GE Scholar Jul 23, 2012 PACE Performance on Post-Discharge Primary Care Evaluations from Jan-Jun 2012 PACE By: Rocio Solano Padilla PCLP-NMF/GE Scholar Jul 23, 2012 2 INTRODUCTION Who am I? Physician Assistant student Towson/CCBC

More information

Medication Safety & Electrolyte Administration. Objectives. High Alert Medications. *Med Safety Electrolyte Administration

Medication Safety & Electrolyte Administration. Objectives. High Alert Medications. *Med Safety Electrolyte Administration Medication Safety & Electrolyte Administration Jennifer Doughty, PharmD PGY2 Pharmacy Resident Emergency Medicine Stormont Vail Health, Topeka, KS Objectives Define and identify high alert medications

More information